Xenetic Bio Share Discussion Threads

[earnestwipplethwaiteiii] 20/1/2014 10:58

kloos2 - if that's your 159k that's just appeared, it's not surprising that you hit the bid out - for an illiquid stock like XEN that's a fairly substantial sell order, so the MMs would only take it at a discount to the current bid. If you had taken the sell into your own hands and sold in tranches you could probably have got them away at a better price, but that's water under the bridge now...

[kloos2] 20/1/2014 10:39

Thanks Hey Ho. To be fair, I have just dug out the letter from them and they stated that they would be selling at any time from 10th Jan. Shame I didn't pay more attention to that or I would have sold at the mini peak last week! It's all a learning curve.

[heyho2] 20/1/2014 10:38

kloos2Don't know them but I see its a brand name for Jarvis Investment Management, might be worth a letter to customer services. They may offer you something.I sometimes think that with these cheap on line brokers you get what you pay for in terms of service.I recently changed broker as mine was slow to communicate and often executed limit orders when the price action should not have triggered them.

[heyho2] 20/1/2014 10:25

Kloos2Who is your broker?

[kloos2] 20/1/2014 10:15

What the.... My broker has just automatically sold my holding at 5.8 when the selling price (I checked 30 mins ago) is 6.45!!! Not happy about that but that's the price they got and there's nothing I can do about it.

[earnestwipplethwaiteiii] 18/1/2014 11:06

heyho - You'd have thought they would spell "scientist" correctly....oh well, it's probably just the copy editor's fault.

[buywell2] 17/1/2014 21:58

I have high hopes for XEN

Soon I hope to see it playing catchup with CRX and SBS

[earnestwipplethwaiteiii] 16/1/2014 02:00

alimo - I'm not sure why you throw out such an unfounded accusation. In my extensive experience XEN's CEO has bent over backwards to be accessible and to give a realistic view of the company's situation. You could do worse than put your questions to the Company; in contrast to perhaps 75% of AIM-listed companies, XEN usually responds.
It's no secret that for the past two years XEN has been pursuing a US listing. The reasons for this have been plainly stated again and again in RNSs. It has been a rotten period for all XEN's investors but we are approaching the pay off. It's true that the move involves making your own personal arrangements, but it's not rocket science - there are several brokers who will handle OTCQB, some of which have been mentioned on this and other boards.
Anyway, if you are disgruntled you can always hit the sell button. I'm staying - and looking forward to a pay day soon.

[alimo] 16/1/2014 01:39

Maybe it's all part of their plan - ditch the small UK pi's. We help them get so far and are then expendable!

[earnestwipplethwaiteiii] 14/1/2014 13:47

Some of these are still grey areas with conflicting information. As I said, best to check to your own satisfaction.

[gregoryan] 14/1/2014 13:23

Hargreaves Lansdown will not trade them.

[earnestwipplethwaiteiii] 14/1/2014 13:16

Some ideas if your current broker won't/cannot trade GAIFD (but please ascertain yourself that they are able):

Hargreaves Lansdown
Schwab UK
Barclays
TD Waterhouse
?NatWest
Killick (but bespoke broker (= heavy commission)

[gregoryan] 14/1/2014 12:46

Both for UK stocks. Not sure regarding the US.

[alasdair100new] 14/1/2014 12:42

thanks Gregoryan - is that totally direct there? or can I phone them and give them an order to work?

[gregoryan] 14/1/2014 12:39

alasdair100new

TD Direct Investing will be able to trade GAIFD.

[alasdair100new] 14/1/2014 12:32

sorry if this has been posted before -my broker simply doesnt know if they will be able to trade GAIF shares or not

do any of you have a concrete positive answer from your brokers that they will be trading the new stock once we hit the US?

Im tempted to ask for my share certs and transfer my holding to a broker who will definitely be trading them

any help much appreciated!

Al

[poppa wobbler] 14/1/2014 10:10

ADVFN won't delete any XEN bulletin boards. They will always be accessable.

However, if you access this bulletin board via the ADVFN monitor, XEN will be deleted when it delists from AIM. So the easiest thing to do is to just save the HTTP link for the bulletin board. (eg: in a Favourites folder, or similar).

[holly_dog] 14/1/2014 10:08

On google finance they haven't adjusted the number of shares...

Current market cap = £2.2bn!



Bit frustrating how we have dropped straight back down, can only think short termers that jumped in on the way up with no research are now dumping as they actually realise what is happening with the company, and Singer happily collecting shares to then make a turn for one last leg up.

[earnestwipplethwaiteiii] 14/1/2014 09:30

corrientes - my guess is it will stay open unless another company takes up the EPIC, as we did from Xenova, now defunct.

[corrientes] 14/1/2014 09:07

Will this board remain open after the move in whatever form ?

[heyho2] 14/1/2014 08:32

Interesting to note that it looks like Ash's consolidation occurred today with GAIF now listed at $15 ps. Also of note is that the epic GAIFD:OTCBB now exists and is listed as Xenetic Bioscience.Almost there!

[ashthorpedo] 12/1/2014 18:52

General Sales and Leasing Inc will change it name to Xenetic Biosciences Inc on or around 14 January 2014.

hxxp://www.4-traders.com/GENERAL-SALES-AND-LEASING-12668312/news/General-Sales-and-Leasing-Inc--GENERAL-SALES--LEASING-INC-10-Q-Managements-Discussion-and-A-17783205/

General Sales and Leasing Inc : GENERAL SALES & LEASING, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations

During the fourth quarter of our fiscal year ended August 31, 2013, we entered into discussions with Xenetic Biosciences plc ("XEN") regarding a potential all share offer for the entire issued and to be issued share capital of XEN (the "Acquisition"). On November 12, 2013, we reached an agreement on the terms of a recommended proposal for the Acquisition under which we will acquire the entire issued and to be issued share capital of XEN. As XEN is a UK based company trading on the AIM London Stock Exchange, the Acquisition is to be effected by means of a scheme of arrangement (the "Scheme") under Part 26 of the Companies Act in the UK by filing a Part 8 Claim with the High Court in London (which was filed on or about November 21, 2013). The Scheme needs to be approved by both 75% of the shareholders of XEN as well as the High Court in London (after a determination of fairness of the transaction) before becoming effective. On December 17, 2013, XEN announced that a majority in number of Xenetic Shareholders who voted (either in person or by proxy), representing 99.9% per cent by value of all Xenetic Shares held by such Xenetic Shareholders, voted in favor of the resolution to approve the Scheme. In addition, a special resolution to facilitate the implementation of the Scheme was passed by the requisite majority of the XEN shareholder votes cast in person or by proxy.

On November 12, 2013, as part of the Scheme, we also entered into an Agreement of Conveyance, Transfer and Assignment of Subsidiaries and Assumption of Obligations with our largest shareholder, Oxbridge Technology Partners, SA ("Oxbridge"), pursuant to which Oxbridge will acquire all of the rights to our current business operations through the purchase of all the shares of our two wholly owned subsidiaries, Shift It Media and General Aircraft, Inc. (the "Hive Out" Agreement). Under the Hive Out Agreement, Oxbridge will cancel its 100,000,000 Common Shares in exchange for: (a) the shares of our two subsidiaries, and (b) the payment of US$430,000 in cash, subject, among other things, to the Scheme becoming Effective. The assets and liabilities associated with such businesses will thereby be transferred to Oxbridge and Oxbridge's 100,000,000 Shares will be cancelled and returned to treasury once the Scheme becomes effective.

Under the Scheme, we will issue to the XEN shareholders 56 shares of our common stock for each 175 shares of their common stock. This will result in our immediately issuing an expected total of 130,520,137 shares of our common stock to the XEN Shareholders, which, following our planned 10 to 1 reverse share split and the cancelation of the shares held by Oxbridge in the Hive Out Agreement, will represent over 97% of our issued and outstanding shares.

5


Table of Contents



As an additional step toward completion of the Acquisition, our board of directors and a majority of our shareholders have approved a change in our corporate name to "Xenetic Biosciences, Inc." and a reverse split of our common stock on a 1 for 10 basis. In connection with the reverse split, the par value of our common stock will also be increased from $0.001 to $0.01 per share. The effective date of these changes in the U.S. over-the-counter securities markets is expected to be on or about January 14, 2014, pending final approval of their effectiveness by FINRA. In the event that the Acquisition is consummated, certain of the officers and directors of XEN will assume management of our company, and, upon the divestment of our aircraft and advertising subsidiaries, we will focus our business activities exclusively on the business of XEN.

[heyho2] 12/1/2014 18:39

Holly_dog

Like you I'll be looking to top up on any weakness in the next week as I believe that there are great gains to be made following a US listing (NASDAQ maybe?), though this may take a few months to achieve. The current market cap of circa £27M is clearly undervalued given the drug pipeline, the advanced stage of trials and the relatively low risk of the drugs being developed (i.e. improving existing formulations).

Is a target of $202M possible shortly after moving to the US? Absolutely, and especially with trial results due in the next year to get new investors excited in the company.

I firmly believe that a market cap of $400M is possible in the next 24 months depending upon trials results and timescales for listing on a main US exchange, which is clearly a massive increase from where we are today and underlines the reason for the move.

GLA holders